Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 703

1.

Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.

Ioannou GN, Perkins JD, Carithers RL Jr.

Gastroenterology. 2008 May;134(5):1342-51. doi: 10.1053/j.gastro.2008.02.013. Epub 2008 Feb 13.

PMID:
18471511
2.

An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.

Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, Satwah S, Shukla R, Buell J.

Liver Transpl. 2006 Oct;12(10):1519-22.

3.

A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.

Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.

Liver Transpl. 2007 Jun;13(6):857-66.

4.
5.

Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.

Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Huang YH, Lee PC, Chang FY, Lee SD.

Liver Transpl. 2004 Dec;10(12):1507-13.

6.
7.

Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.

Moonka D, Castillo E, Kumer S, Abouljoud M, Divine G, Pelletier S.

Transplant Proc. 2009 Jan-Feb;41(1):216-8. doi: 10.1016/j.transproceed.2008.09.060.

PMID:
19249517
8.

Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation.

Sharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC, Wiesner RH, Balan V.

Am J Transplant. 2006 Aug;6(8):1957-62. Epub 2006 Jun 9.

9.

Liver transplantation for hepatocellular carcinoma: the MELD impact.

Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.

Liver Transpl. 2004 Jan;10(1):36-41.

11.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

12.

Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.

Levi DM, Tzakis AG, Martin P, Nishida S, Island E, Moon J, Selvaggi G, Tekin A, Madrazo BL, Narayanan G, Garcia MT, Feun LG, Tryphonopoulos P, Skartsis N, Livingstone AS.

J Am Coll Surg. 2010 May;210(5):727-34, 735-6. doi: 10.1016/j.jamcollsurg.2010.01.007.

PMID:
20421039
13.

Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.

Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, Wachs M, Bak T, Kam I, Everson GT.

Liver Transpl. 2004 Jan;10(1):42-8.

14.

A disease-based comparison of liver transplantation outcomes.

Mailey B, Buchberg B, Prendergast C, Artinyan A, Khalili J, Sanchez-Luege N, Colquhoun SD, Kim J.

Am Surg. 2009 Oct;75(10):901-8.

PMID:
19886131
15.

Survival benefit after liver transplantation: a single European center experience.

Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.

Transplantation. 2009 Sep 27;88(6):826-34. doi: 10.1097/TP.0b013e3181b26807.

PMID:
19920783
16.

Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.

Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T.

Liver Transpl. 2012 Apr;18(4):423-33. doi: 10.1002/lt.23385.

17.

Greater travel time to a liver transplant center does not adversely affect clinical outcomes.

Firozvi AA, Lee CH, Hayashi PH.

Liver Transpl. 2008 Jan;14(1):18-24.

18.

Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.

Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.

Am J Gastroenterol. 2005 Dec;100(12):2708-16.

PMID:
16393224
19.
20.

Supplemental Content

Support Center